Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Chronic Heart Failure

  Free Subscription


Articles published in J Mol Cell Cardiol

Retrieve available abstracts of 48 articles:
HTML format



Single Articles


    June 2022
  1. WEERTS J, Mourmans SGJ, Eringa E, van Empel VPM, et al
    Improving insights into the heterogeneous HFpEF syndrome through microvascular research.
    J Mol Cell Cardiol. 2022;167:106-108.
    PubMed    


  2. EMTER CA
    A 'Swine Time' for HFpEF: Multiple animal models for a myriad of clinical phenotypes.
    J Mol Cell Cardiol. 2022;167:15-16.
    PubMed    


    May 2022
  3. CHENG G, Zhu D, Huang K, Caranasos TG, et al
    Minimally invasive delivery of a hydrogel-based exosome patch to prevent heart failure.
    J Mol Cell Cardiol. 2022 May 3. pii: S0022-2828(22)00085.
    PubMed     Abstract available


  4. KANASSATEGA RS, Bunch TA, Lepak VC, Wang C, et al
    Human cardiac myosin-binding protein C phosphorylation- and mutation-dependent structural dynamics monitored by time-resolved FRET.
    J Mol Cell Cardiol. 2022;166:116-126.
    PubMed     Abstract available


  5. ZHAO Y, Godier-Furnemont A, Bax NAM, Bouten CVC, et al
    Changes in extracellular matrix in failing human non-ischemic and ischemic hearts with mechanical unloading.
    J Mol Cell Cardiol. 2022;166:137-151.
    PubMed     Abstract available


    April 2022
  6. SEDEJ S, Abdellatif M
    Metabolic therapy for managing heart failure with preserved ejection fraction.
    J Mol Cell Cardiol. 2022;168:68-69.
    PubMed    


  7. MOTURI S, Ghosh-Choudhary SK, Finkel T
    Cardiovascular disease and the biology of aging.
    J Mol Cell Cardiol. 2022;167:109-117.
    PubMed     Abstract available


  8. WANG C, Zhang Y, Methawasin M, Braz CU, et al
    RBM20(S639G) mutation is a high genetic risk factor for premature death through RNA-protein condensates.
    J Mol Cell Cardiol. 2022;165:115-129.
    PubMed     Abstract available


    March 2022
  9. GARBINCIUS JF, Luongo TS, Jadiya P, Hildebrand AN, et al
    Enhanced NCLX-dependent mitochondrial Ca(2+) efflux attenuates pathological remodeling in heart failure.
    J Mol Cell Cardiol. 2022;167:52-66.
    PubMed     Abstract available


  10. ABDELLATIF M, Kroemer G
    Heart failure with preserved ejection fraction: An age-related condition.
    J Mol Cell Cardiol. 2022;167:83-84.
    PubMed    


  11. DYCK JRB, Sossalla S, Hamdani N, Coronel R, et al
    Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: Evidence for potential off-target effects.
    J Mol Cell Cardiol. 2022;167:17-31.
    PubMed     Abstract available


  12. WANG YL, Bai L, Shi XR, Zhu H, et al
    Osteoblast MR deficiency protects against adverse ventricular remodeling after myocardial infarction.
    J Mol Cell Cardiol. 2022 Mar 18. pii: S0022-2828(22)00047.
    PubMed     Abstract available


  13. QIU Y, Pan X, Chen Y, Xiao J, et al
    Hallmarks of exercised heart.
    J Mol Cell Cardiol. 2022;164:126-135.
    PubMed     Abstract available


  14. WANG N, Dries E, Fowler ED, Harmer SC, et al
    Inducing Ito,f and phase 1 repolarization of the cardiac action potential with a Kv4.3/KChIP2.1 bicistronic transgene.
    J Mol Cell Cardiol. 2022;164:29-41.
    PubMed     Abstract available


  15. TANI H, Tohyama S, Kishino Y, Kanazawa H, et al
    Production of functional cardiomyocytes and cardiac tissue from human induced pluripotent stem cells for regenerative therapy.
    J Mol Cell Cardiol. 2022;164:83-91.
    PubMed     Abstract available


    February 2022
  16. ESCHENHAGEN T, Ridders K, Weinberger F
    How to repair a broken heart with pluripotent stem cell-derived cardiomyocytes.
    J Mol Cell Cardiol. 2022;163:106-117.
    PubMed     Abstract available


  17. STENZIG J, Lemoine MD, Stoter AMS, Wrona KM, et al
    Recapitulation of dyssynchrony-associated contractile impairment in asymmetrically paced engineered heart tissue.
    J Mol Cell Cardiol. 2022;163:97-105.
    PubMed     Abstract available


    January 2022
  18. LIU X, Zhang Y, Deng Y, Yang L, et al
    Mitochondrial protein hyperacetylation underpins heart failure with preserved ejection fraction in mice.
    J Mol Cell Cardiol. 2022;165:76-85.
    PubMed     Abstract available


    November 2021
  19. CHAPSKI DJ, Cabaj M, Morselli M, Mason RJ, et al
    Early adaptive chromatin remodeling events precede pathologic phenotypes and are reinforced in the failing heart.
    J Mol Cell Cardiol. 2021;160:73-86.
    PubMed     Abstract available


    October 2021
  20. CAGGIANO LR, Holmes JW, Witzenburg CM
    Individual variability in animal-specific hemodynamic compensation following myocardial infarction.
    J Mol Cell Cardiol. 2021 Oct 28. pii: S0022-2828(21)00207.
    PubMed     Abstract available


    September 2021
  21. DAVIS K, Azarcon P, Hickenlooper S, Bia R, et al
    The role of demethylases in cardiac development and disease.
    J Mol Cell Cardiol. 2021;158:89-100.
    PubMed     Abstract available


  22. SHEN S, Sewanan LR, Campbell SG
    Evidence for synergy between sarcomeres and fibroblasts in an in vitro model of myocardial reverse remodeling.
    J Mol Cell Cardiol. 2021;158:11-25.
    PubMed     Abstract available


  23. RITTERHOFF J, McMillen TS, Villet O, Young S, et al
    Increasing fatty acid oxidation elicits a sex-dependent response in failing mouse hearts.
    J Mol Cell Cardiol. 2021;158:1-10.
    PubMed     Abstract available


    August 2021
  24. AKSENTIJEVIC D, Shattock MJ
    With a grain of salt: Sodium elevation and metabolic remodelling in heart failure.
    J Mol Cell Cardiol. 2021 Aug 6. pii: S0022-2828(21)00156.
    PubMed     Abstract available


    July 2021
  25. MASHALI MA, Saad NS, Canan BD, Elnakish MT, et al
    Impact of etiology on force and kinetics of left ventricular end-stage failing human myocardium.
    J Mol Cell Cardiol. 2021;156:7-19.
    PubMed     Abstract available


    June 2021
  26. PATEREK A, Okninska M, Chajduk E, Polkowska-Motrenko H, et al
    Systemic iron deficiency does not affect the cardiac iron content and progression of heart failure.
    J Mol Cell Cardiol. 2021;159:16-27.
    PubMed     Abstract available


  27. GARNIER A, Bork NI, Jacquet E, Zipfel S, et al
    Mapping genetic changes in the cAMP-signaling cascade in human atria.
    J Mol Cell Cardiol. 2021;155:10-20.
    PubMed     Abstract available


    May 2021
  28. YAN J, Killingsworth C, Walcott G, Zhu Y, et al
    Molecular remodeling of Cx43, but not structural remodeling, promotes arrhythmias in an arrhythmogenic canine model of nonischemic heart failure.
    J Mol Cell Cardiol. 2021 May 25. pii: S0022-2828(21)00106.
    PubMed     Abstract available


  29. IGAKI Y, Tanno M, Sato T, Kouzu H, et al
    Xanthine oxidoreductase-mediated injury is amplified by upregulated AMP deaminase in type 2 diabetic rat hearts under the condition of pressure overload.
    J Mol Cell Cardiol. 2021;154:21-31.
    PubMed     Abstract available


  30. MCCABE KJ, Rangamani P
    Computational modeling approaches to cAMP/PKA signaling in cardiomyocytes.
    J Mol Cell Cardiol. 2021;154:32-40.
    PubMed     Abstract available


    February 2021
  31. RATTKA M, Westphal S, Gahr BM, Just S, et al
    Spen deficiency interferes with Connexin 43 expression and leads to heart failure in zebrafish.
    J Mol Cell Cardiol. 2021 Feb 4. pii: S0022-2828(21)00022.
    PubMed     Abstract available


  32. HINGER SA, Wei J, Dorn LE, Whitson BA, et al
    Remodeling of the m(6)A landscape in the heart reveals few conserved post-transcriptional events underlying cardiomyocyte hypertrophy.
    J Mol Cell Cardiol. 2021;151:46-55.
    PubMed     Abstract available


    December 2020
  33. MORA MT, Gong JQX, Sobie EA, Trenor B, et al
    The role of beta-adrenergic system remodeling in human heart failure: A mechanistic investigation.
    J Mol Cell Cardiol. 2020 Dec 13. pii: S0022-2828(20)30344.
    PubMed     Abstract available


  34. MAMIC P, Chaikijurajai T, Tang WHW
    Gut microbiome - A potential mediator of pathogenesis in heart failure and its comorbidities: State-of-the-art review.
    J Mol Cell Cardiol. 2020 Dec 8. pii: S0022-2828(20)30340.
    PubMed     Abstract available


  35. CORTASSA S, Juhaszova M, Aon MA, Zorov DB, et al
    Mitochondrial Ca(2+), redox environment and ROS emission in heart failure: Two sides of the same coin?
    J Mol Cell Cardiol. 2020 Dec 7. pii: S0022-2828(20)30336.
    PubMed     Abstract available


  36. O'ROURKE B, Ashok D, Liu T
    Mitochondrial Ca(2+) in heart failure: Not enough or too much?
    J Mol Cell Cardiol. 2020 Dec 5. pii: S0022-2828(20)30337.
    PubMed     Abstract available


  37. NOMURA S, Komuro I
    Precision medicine for heart failure based on molecular mechanisms The Research Achievement Award Lecture.
    J Mol Cell Cardiol. 2020 Dec 1. pii: S0022-2828(20)30333.
    PubMed     Abstract available


    November 2020
  38. ROLLE IG, Crivellari I, Zanello A, Mazzega E, et al
    Heart failure impairs the mechanotransduction propeties of human cardiac pericytes.
    J Mol Cell Cardiol. 2020;151:15-30.
    PubMed     Abstract available


    September 2020
  39. ZHANG M, Yang X, Zimmerman RJ, Wang Q, et al
    CaMKII exacerbates heart failure progression by activating class I HDACs.
    J Mol Cell Cardiol. 2020 Sep 21. pii: S0022-2828(20)30287.
    PubMed     Abstract available


  40. MISTRY P, Reitz CJ, Khatua TN, Rasouli M, et al
    Circadian influence on the microbiome improves heart failure outcomes.
    J Mol Cell Cardiol. 2020 Sep 19. pii: S0022-2828(20)30286.
    PubMed     Abstract available


  41. STOLEN TO, Hoydal MA, Ahmed MS, Jorgensen K, et al
    Exercise training reveals micro-RNAs associated with improved cardiac function and electrophysiology in rats with heart failure after myocardial infarction.
    J Mol Cell Cardiol. 2020 Sep 9. pii: S0022-2828(20)30272.
    PubMed     Abstract available


    July 2020
  42. SHANG L, Yue W, Wang D, Weng X, et al
    Systolic overload-induced pulmonary inflammation, fibrosis, oxidative stress and heart failure progression through interleukin-1beta.
    J Mol Cell Cardiol. 2020 Jul 23. pii: S0022-2828(20)30230.
    PubMed     Abstract available


    May 2020
  43. TIAN C, Hu G, Gao L, Hackfort BT, et al
    Extracellular vesicular MicroRNA-27a* contributes to cardiac hypertrophy in chronic heart failure.
    J Mol Cell Cardiol. 2020 May 1. pii: S0022-2828(20)30122.
    PubMed     Abstract available


    March 2020
  44. RAZAVI AC, Bazzano LA, He J, Li S, et al
    Pseudouridine and N-formylmethionine associate with left ventricular mass index: Metabolome-wide association analysis of cardiac remodeling.
    J Mol Cell Cardiol. 2020;140:22-29.
    PubMed     Abstract available


    February 2020
  45. KELLEY RC, McDonagh B, Brumback B, Walter GA, et al
    Diaphragm weakness and proteomics (global and redox) modifications in heart failure with reduced ejection fraction in rats.
    J Mol Cell Cardiol. 2020 Feb 5. pii: S0022-2828(20)30026.
    PubMed     Abstract available


    January 2020
  46. ALI HR, Michel CR, Lin YH, McKinsey TA, et al
    Defining decreased protein succinylation of failing human cardiac myofibrils in ischemic cardiomyopathy.
    J Mol Cell Cardiol. 2020;138:304-317.
    PubMed     Abstract available


    December 2019
  47. HELISTE J, Chheda H, Paatero I, Salminen TA, et al
    Genetic and functional implications of an exonic TRIM55 variant in heart failure.
    J Mol Cell Cardiol. 2019 Dec 19. pii: S0022-2828(19)30398.
    PubMed     Abstract available


    December 2018
  48. BOITARD SE, Marc Y, Keck M, Mougenot N, et al
    Brain renin-angiotensin system blockade with orally active aminopeptidase A inhibitor prevents cardiac dysfunction after myocardial infarction in mice.
    J Mol Cell Cardiol. 2018 Dec 29. pii: S0022-2828(18)30783.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: